In this article

Your cholesterol conversation just got bigger.

Your cholesterol came back. Maybe your LDL was a little high. Maybe it was called fine. You were told to eat well, exercise, and check it again next year. And that was pretty much the end of the conversation.

On March 13, 2026, the American College of Cardiology, American Heart Association, and other medical groups released the first full replacement of the major U.S. cholesterol guideline since 2018.

The guidance now takes a broader look at cholesterol and other fats and particles in the blood. What does that mean for you? Your usual cholesterol test may not tell your entire heart story.

For women, some of the information that matters may come from years before the blood draw: a pregnancy complication, when menopause began, or heart disease in the family.

Your LDL still matters. It just is not the whole conversation.

LDL is the cholesterol often called bad cholesterol. The particles carrying it can contribute to plaque, the buildup in artery walls. Lowering LDL remains an important way to reduce the risk of heart attack and stroke.

But two women can have the same LDL and different risks. Diabetes, family history, high Lp(a), earlier preeclampsia, or plaque already present can change what that number means for care.

Same LDL. Different story.

A lab result is a photograph. A decade of results is a movie.

There is a cholesterol-related test you may never have had.

It is called the lipoprotein(a) test, usually written as Lp(a). It measures a type of particle that carries cholesterol in your blood. Your genes largely determine how much you have. It is not part of the usual cholesterol test.

The 2026 guideline recommends checking Lp(a) at least once in adulthood. That recommendation is not limited to people who already have heart disease.

Lp(a) is largely inherited, so one measurement is often enough. If an earlier result was intermediate, between clearly low and high, ask whether repeating it could change your risk assessment or prevention plan, particularly after menopause. Pregnancy, kidney disease and an underactive thyroid (hypothyroidism) can also affect the result; your clinician can decide whether and when to repeat it. Menopause alone does not mean you need routine repeat testing.

A result of 125 nmol/L or higher, or 50 mg/dL or higher, can add to your risk of heart attack and stroke. Labs use different units, so check which one is on your report. There is no single reliable formula for converting between them.

A high result does not predict that you will have a heart attack. It helps your care team decide how closely to manage LDL, blood pressure, and other risks. Food and exercise usually change the Lp(a) number very little, but they still matter to the rest of your heart health.

ApoB may add something your LDL does not.

LDL cholesterol measures the amount of cholesterol inside LDL particles. ApoB helps count the particles that can contribute to plaque. The amount of cholesterol and the number of particles do not always tell the same story.

ApoB can be useful for some people with type 2 diabetes, high triglycerides, or known artery disease. Triglycerides are another kind of fat measured in blood tests. Your clinician may consider ApoB when your usual cholesterol results leave questions about your risk.

Not every woman needs ApoB. The useful question is whether the result would change her care. Neither ApoB nor Lp(a) shows whether plaque is already present.

Sometimes a scan can help when the treatment decision is unclear.

Risk is probability. Plaque is anatomy. Fitness is capacity.

A coronary artery calcium scan, or CAC scan, is a low-dose CT scan that looks for calcium in plaque in the arteries supplying the heart. It can sometimes help when you and your clinician are unsure whether to start cholesterol-lowering treatment.

For women, a calcium scan may be considered from age 45 if a risk estimate leaves the treatment decision unclear. The guideline calls these the borderline and intermediate risk groups. A scan should help you and your clinician decide what to do; turning 45 alone is not a reason to have one.

A calcium scan cannot show every kind of plaque, and a score of zero does not mean zero risk. It is also not a substitute for evaluating new chest pain or other concerning symptoms.

Ask: “Would this scan change what you recommend for me?”

Your pregnancy history belongs in the conversation.

Why should something that happened during pregnancy twenty years ago matter to your cholesterol now? Because some pregnancy complications are linked with a greater chance of heart and blood-vessel disease later in life.

Pregnancy history mattered before this update. The 2018 guideline already included preeclampsia and menopause before age 40. The 2026 guideline gives more attention to what happened during pregnancy and when menopause began.

That includes preeclampsia, high blood pressure during pregnancy, diabetes during pregnancy, and a baby born early. Tell your care team about menopause before age 45, too. Polycystic ovary syndrome, or PCOS, is also discussed in the guidance, so mention it if it is part of your history.

These histories do not, by themselves, mean you have cardiovascular disease. They still belong in your prevention discussion.

The pregnancy ended. The information did not. It can help your clinician understand your risk and decide with you whether treatment makes sense. It does not automatically mean you need medicine.

The calculator changed. Your history still matters.

Your clinician may use a calculator called PREVENT to estimate your chance of a heart attack or stroke. The new guideline uses its ten-year estimate for adults ages 30 to 79 who meet the criteria. A thirty-year estimate is available for adults ages 30 to 59.

For cholesterol decisions, this calculator is used when LDL is 70 to 189 mg/dL and no artery plaque or disease caused by it has been identified. If that does not describe you, your clinician may use a different approach. No calculator can tell you exactly what will happen.

Your clinician then adds information the calculator leaves out, including pregnancy complications, early menopause, family history, and Lp(a). If the treatment decision is still unclear, a calcium scan may help some women decide.

Bring older results when you have them. How long your cholesterol has been high matters as well as today’s number. Understanding the pattern can help you and your care team act earlier when your overall risk calls for it.

Cholesterol goals are back.

Your clinician will look at how far your LDL has fallen and the number you are trying to reach. The guideline brings back specific LDL and non-HDL cholesterol goals. Non-HDL is your total cholesterol minus HDL, often called good cholesterol.

These LDL goals are examples, not personal targets. Your care team should explain which goal applies to you and why. Other conditions and test results can change the recommendation.

  • Below 100 mg/dL for people being treated to prevent a first heart attack or stroke whose estimated risk is borderline or intermediate.
  • Below 70 mg/dL for people being treated to prevent a first heart attack or stroke whose estimated risk is high.
  • Below 55 mg/dL for people who already have disease caused by artery plaque and are at very high risk of further events.

The HEART RESERVE takeaway

Your earlier health history can help explain what deserves attention now. Pregnancy, blood pressure, cholesterol, blood sugar, menopause, symptoms, family history, tests, and fitness may have happened years apart. They still belong in the same heart story.

Start by gathering what you know. Your Heart Story can help you put the pieces in one place before a visit. You do not need perfect records or a request for every test.

Food, movement, sleep, and avoiding tobacco still matter. Some people also need cholesterol medicine. Tell your prescriber if you are pregnant, planning pregnancy, or breastfeeding, because that can change which medicines are suitable. Do not start, stop, or change a medicine based on this article.

One question to bring into care: “When you look at my results and my history together, what should we do next?”

Build the heart you need now.

Your next step

Bring the old and new results together

Put your latest lipid panel beside the previous result. Add any Lp(a) result, family history of early heart disease and relevant pregnancy or menopause details. If treatment is being considered, ask how the expected benefit applies to you.

Before you leave, confirm the next step, when it should happen, and who will follow up.

Free. No account needed. Use your notes with your care team.

Evidence behind the article

Sources and editorial review

Sources last checked:

  1. 2026 Guideline on the Management of DyslipidemiaACC/AHA Multisociety Guideline · Circulation · 2026
  2. ACC/AHA Issue Updated Guideline for Managing Lipids, CholesterolAmerican College of Cardiology · March 13, 2026
  3. ACC, AHA Release New Clinical Guideline For Managing DyslipidemiaAmerican College of Cardiology · 2026
  4. Lower Sooner: How the 2026 Dyslipidemia Guideline Changes PracticeAmerican College of Cardiology · 2026
  5. Key Patient Messages: 2026 Guideline on the Management of DyslipidemiaAmerican Heart Association · 2026
  6. 2018 Cholesterol Guideline: Primary and Secondary Prevention OverviewAmerican College of Cardiology · 2018
  7. 2025 ESC/EAS cholesterol guideline updateEuropean Society of Cardiology / European Atherosclerosis Society · 2025
  8. An Update on Lipoprotein(a): Testing and Risk BackgroundAmerican College of Cardiology · 2023
  9. Plain Language Summary of the 2026 Dyslipidemia GuidelineAmerican Heart Association · 2026
  10. Using PREVENT-ASCVD Equations for Risk-Based Lipid ManagementAmerican Heart Association · Clinician take-home messages · 2026

Independent clinical review is identified only when it has been completed and approved in writing. No external reviewer or organization is implied. Sources do not imply endorsement of HEART RESERVE.